PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Primary and Secondary endpoints met in MPS I Trial, page-13

  1. 184 Posts.
    lightbulb Created with Sketch. 40
    Give it a few mins, only up a couple of cents now.

    The share price won't sustain a move north until future funding is all sorted. The longer it drags on the more shares the Big Boys will get when they raise.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.